Aandeel BIIB BIOGEN INC.
Toevoegen aan een lijst

Verbindingen Biogen Inc.

Aandelen

BIIB

US09062X1037

Farmaceutische producten

Beurs gesloten - Nasdaq
Andere beurzen
 22:00:00 08-12-2025 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
180,44 USD -0,47% Intraday-grafiek van Biogen Inc. +1,50% +18,00%
05/12 Stoke Therapeutics, Inc. en Biogen Inc. presenteren gegevens die het ziekteveranderende potentieel van zorevunersen, een onderzoeksgeneesmiddel voor de behandeling van het syndroom van Dravet, verder ondersteunen CI
05/12 Stoke Therapeutics en Biogen presenteren gegevens die het ziekte-modificerende potentieel van zorevunersen verder ondersteunen RE

50

Beursgenoteerde bedrijven

50

Bedrijven in privébezit

434

Insiders

Relatiegrafiek van verwante beursgenoteerde bedrijven: Biogen Inc.

Actieve relaties

Relaties uit het verleden

Verwante beursgenoteerde bedrijven: Biogen Inc.

ARCHER-DANIELS-MIDLAND COMPANY
Monish Patolawala
INCYTE CORPORATION
Paul Clancy
Benjamin Strain
INTERNATIONAL FLAVORS & FRAGRANCES INC.
Richard Mulligan
Jesus Mantas
REPLIGEN CORPORATION
Nicolas Barthelemy
Rohin Mhatre
NEUROCRINE BIOSCIENCES, INC.
Stephen Sherwin
William Rastetter
IMUNON, INC.
James Dentzer
Stacy Lindborg
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Maria Freire
BAYER AG
Nancy Simonian
William Anderson
EXELIXIS, INC.
Stelios Papadopoulos
Maria Freire
CURIS, INC.
James Dentzer
Diantha Duvall
ILLUMINA, INC.
Caroline Dorsa
COLLEGIUM PHARMACEUTICAL, INC.
Arun Padmanabhan
Scott Dreyer
AGIOS PHARMACEUTICALS, INC.
Jeffrey Capello
Cecilia Jones
Sarah Gheuens
ASTRIA THERAPEUTICS, INC.
Ken Bate
Ben Harshbarger
John Ruesch
SQZ BIOTECHNOLOGIES COMPANY
Richard Capasso
Patrick Volkert Vink
Marc Schegerin
David First
ARTELO BIOSCIENCES, INC.
Connie Matsui
Gregory Reyes
Gregory Gorgas
DUKE ENERGY CORPORATION
Caroline Dorsa
BLACKSTONE INC.
William Young
John Maraganore
Kiran Reddy
MIMEDX GROUP, INC.
William Hawkins
KARYOPHARM THERAPEUTICS INC.
Michael Mano
Lisa DiPaolo
CARIS LIFE SCIENCES, INC.
Lloyd Minor
BAUSCH HEALTH COMPANIES INC.
Richard Mulligan
VERASTEM, INC.
Eric Rowinsky
Michael Kauffman
Robert Gagnon
ALKERMES PLC
David Gaffin
C. Nichols
INNOVENT BIOLOGICS, INC.
Stephen Sherwin
PURPLE BIOTECH LTD
Eric Rowinsky
Robert Gagnon
SPERO THERAPEUTICS, INC.
Patrick Volkert Vink
Kathleen Tregoning
EDITAS MEDICINE, INC.
Andrew Hirsch
Gilmore O’Neill
Linda Burkly
VOYAGER THERAPEUTICS, INC.
George Scangos
Glenn Pierce
Alfred Sandrock
Toby Ferguson
ZAI LAB LIMITED
Michel Vounatsos
Frazor Edmondson
INTELLIA THERAPEUTICS, INC.
James Basta
Marika St Amand
Eliana Clark
ABSCI CORPORATION
Menelas Nicolas Pangalos
KEROS THERAPEUTICS, INC.
Keith Regnante
Alpna Seth
XILIO THERAPEUTICS, INC.
Paul Clancy
Aoife Brennan
BIOVENTUS INC.
William Hawkins
MADRIGAL PHARMACEUTICALS, INC.
Ken Bate
William Sibold
FOGHORN THERAPEUTICS INC.
Adrian Gottschalk
Carlos Costa
CAMP4 THERAPEUTICS CORPORATION
Steven Holtzman
Douglas Williams
Kelly Gold
SCHOLAR ROCK HOLDING CORPORATION
Michael Gilman
David Hallal
Akshay Vaishnaw
Richard Brudnick
EVEREST MEDICINES LIMITED
Eric Rowinsky
AUTOLUS THERAPEUTICS PLC
William Young
Michael Bonney
BEAM THERAPEUTICS INC.
John Maraganore
Chirfi Guindo
SANA BIOTECHNOLOGY, INC.
Richard Mulligan
CLIMB BIO, INC.
Douglas Williams
Susan Altschuller
Aoife Brennan
DYNE THERAPEUTICS, INC.
Brian Posner
Douglas Kerr
John Cox
Johanna Friedl-Naderer
Lucia Celona
ARMATA PHARMACEUTICALS, INC.
Robin Kramer
PRIME MEDICINE, INC.
Michael Kelly
Richard Brudnick
SIONNA THERAPEUTICS, INC.
Paul Clancy
Joanne Viney
Michael Cloonan
Vanya Sagar
RAPPORT THERAPEUTICS, INC.
Robert Perez
John Maraganore
Jeffrey Sevigny
CERVOMED INC.
John Alam
Sylvie Grégoire
Claudia Ordonez

Actieve relaties

Relaties uit het verleden

Relatiegrafiek voor verwante privébedrijven: Biogen Inc.

Actieve relaties

Relaties uit het verleden

Verwante privébedrijven: Biogen Inc.

ARCH Venture Partners LLC

Investment Managers

Vicki Sato
George Scangos
John Maraganore
Advent Venture Partners LLP

Investment Managers

Katrine Bosley
Roy R. Lobb
Bioverativ Therapeutics, Inc.

Pharmaceuticals: Major

Glenn Pierce
William Sibold
Lynne Sullivan
Biotechnology Innovation Organization

Miscellaneous Commercial Services

Steven Holtzman
John Maraganore
Katrine Bosley
Nancy Simonian
William Sibold
Stromedix, Inc.

Pharmaceuticals: Major

Paul Clancy
Michael Dambach
Aitia, Inc.

John Maraganore
David W Miller
4Tech Cardio Ireland Ltd.

William Hawkins
Lawrence C. Best
Dana-Farber Cancer Institute, Inc.

Hospital/Nursing Management

Robert Perez
Susan Alexander
The American Institute of Certified Public Accountants

Miscellaneous Commercial Services

Stephen Wills
Stephen Tulipano
Robin Kramer
Atlas Venture Advisors, Inc.

Investment Managers

John Maraganore
Shelia Violette
Douglas Kerr
Akshay Vaishnaw
Aoife Brennan
Andrea DiMella
The University of California, San Francisco

Other Consumer Services

Stephen Sherwin
Alan B. Glassberg
Georgetown University

Other Consumer Services

Steven Holtzman
Marijn Dekkers
American Society of Clinical Oncology, Inc.

Medical/Nursing Services

Stephen Sherwin
Alessandra Cesano
Jennifer Jackson
National Academy of Sciences

Miscellaneous Commercial Services

Phillip Sharp
Cecil B. Pickett
Pharmaceutical Research & Manufacturers of America

Biotechnology

David Hallal
William Anderson
National Academy of Medicine (United States)

Miscellaneous Commercial Services

Phillip Sharp
Cecil B. Pickett
Maria Freire
American Association for Cancer Research

Miscellaneous Commercial Services

Stephen Sherwin
Alessandra Cesano
Massachusetts Bar Association

Miscellaneous Commercial Services

Timothy P. Linkkila
Karoline Shair
American Society of Hematology

Miscellaneous Commercial Services

Glenn Pierce
Alessandra Cesano
Massachusetts Society of Certified Public Accountants, Inc.

Miscellaneous Commercial Services

Stephen Tulipano
Robin Kramer
Massachusetts Biotechnology Council

Miscellaneous Commercial Services

Paul McKenzie
Gilmore O’Neill
Biogen Idec, Inc. (North Carolina)

Pharmaceuticals: Major

Eric Rowinsky
Lynn Schenk
Stelios Papadopoulos
Matthew Calistri
Michel Vounatsos
Lawrence Gan
F2G Ltd.

Pharmaceuticals: Major

Sylvie Grégoire
Patrick Volkert Vink
Biomedical Sciences Careers Program, Inc.

Robert Perez
James Mullen
George Scangos
Fondation Santé

George Scangos
Stelios Papadopoulos
Spyridon Artavanis-Tsakonas
American Academy of Neurology

Miscellaneous Commercial Services

Alfred Sandrock
Gilmore O’Neill
Third Rock Ventures LLC

Investment Managers

Stephen Sherwin
Richard Ransohoff
Avila Therapeutics, Inc.

Pharmaceuticals: Major

Russell C. Petter
Juswinder Singh
Harvard Medical School

Other Consumer Services

Richard Mulligan
Spyridon Artavanis-Tsakonas
Alfred Sandrock
Biogen Idec Ltd.

Biotechnology

Johanna Friedl-Naderer
Trevor Anthony Mill
Biogen GmbH

Pharmaceuticals: Major

Stephen Sherwin
Nancy L. Leaming
Caroline Dorsa
Eric Rowinsky
Robert W. Pangia
Lynn Schenk
Brian Posner
Alexander Denner
Richard Mulligan
Michel Vounatsos
Longwood Fund Management LLC

Investment Managers

John Maraganore
John McCabe
Alfred Sandrock
PhRMA Foundation

Alfred Sandrock
Mahalakshmi Radhakrishnan
Omega Fund Management LLC

John Maraganore
Menelas Nicolas Pangalos
University of California

Stephen Sherwin
George Scangos
Stanford University School of Medicine

Christopher Viehbacher
Lloyd Minor
Gurnet Point Capital LLC

Christopher Viehbacher
Nithya Desikan
Scholar Rock, Inc.

Michael Gilman
David Hallal
Akshay Vaishnaw
Israel Biotech Fund

Jesse M. Cedarbaum
Richard Brudnick
Morphic Holding, Inc.

Marc Schegerin
Joanne Gibbons
Bioverativ, Inc.

Timothy Harris
William Sibold
Bain Capital Life Sciences LP

Adam Koppel
Ricky Sun
Matthew Calistri
UC San Diego Foundation

William Jones
Lynn Schenk
RA Capital Management LP (Private Equity)

Michael Cloonan
Tess Cameron
Minovia Therapeutics Ltd.

John Cox
Mahalakshmi Radhakrishnan
Cerevel Therapeutics Holdings, Inc.

Kenneth DiPietro
Matthew Calistri
Mark Bodenrader
Nereid Therapeutics, Inc.

Michael Kauffman
Michael Ehlers
Cerevel Therapeutics, Inc.

Marijn Dekkers
Adam Koppel
Hemab ApS

John Maraganore
Akshay Vaishnaw
Stablix, Inc.

Tony Kingsley
Douglas Williams

Actieve relaties

Relaties uit het verleden

Relatiestatistieken

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Activiteiten van verwante bedrijven

Miscellaneous Commercial Services10
Pharmaceuticals: Major10
Investment Managers6
Biotechnology6
Other Consumer Services3
Medical Specialties2
Medical/Nursing Services1
Hospital/Nursing Management1
Pharmaceuticals: Other1
Electric Utilities1

Landen van de verwante bedrijven

Verenigde Staten83
Verenigd Koninkrijk4
Israël3
China3
Ierland2
Duitsland2
Denemarken1
Griekenland1
Canada1

Bedrijfsprofiel

Logo Biogen Inc.
Biogen Inc. is een van marktleiders wereldwijd op het gebied van het ontwerp, de vervaardiging en de verkoop van therapeutische producten. De omzet per inkomstenbron wordt als volgt onderverdeeld: - verkoop van medicijnen (74,6%): bestemd voor de behandeling van multiple sclerose, chronische psoriasis bij volwassenen, reumatische polyartritis, kanker, enz.; - royalty's (6,7%); - overige (18,7%): met name inkomsten uit partnerschapsovereenkomsten.
Werknemers
7.605
Sector
Farmaceutische producten
Agenda
29/01 - Q4 2025 Cijferpublicaties (schatting)
Meer informatie over het bedrijf
  1. Beurs
  2. Aandelen
  3. Koers BIIB
  4. Onderneming Biogen Inc.
  5. Verbindingen

Kies jouw editie

Alle financiële informatie op nationaal niveau

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
Verenigde Staten

MarketScreener is also available in this country: United States.

Switch edition
Ik blijf hier.